C. Vanesa Díaz-García

Author

Hospital Universitario 12 De Octubre ORCID

Also Known As

C. Díaz-García, C. V. Diaz-Garcia, C. Vanesa Diaz-Garcia, C. Vanesa Díaz-García, C.V. Diaz-Garcia, C.V. Díaz-García, Camille Diaz-Garcia, Claudio Díaz-García

Publications

437

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario 12 De Octubre Research Institute Hospital 12 de Octubre Instituto de Salud Carlos III Universidad Autónoma de Madrid Spanish National Cancer Research Centre

About

C. Vanesa Díaz-García is an author at Hospital Universitario 12 De Octubre specializing in medicine, tumor microenvironment, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	168
2	Cell Biology	2	2	73
3	Health Sciences	1	1	49
4	Natural Sciences	1	1	27
5	Biomolecular Engineering	1	1	27

C. Vanesa Díaz-García

Publications

280

Citations

H-Index

Page 1

	Year	Citations
DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification C. Vanesa Díaz-García, Alba Agudo-López, Carlos Pérez‐Plasencia, Carcinogenesis	2013	50
Risk factors associated with Clostridium difficile infection in adult oncology patients Analia Rodríguez Garzotto, Antonio Garcia, Nerea Muñoz Unceta, Supportive Care in Cancer Adult Oncology PatientsHealth SciencesClostridium Difficile InfectionHealthcare-associated InfectionHospital Epidemiology	2014	49
A Polycomb-mir200 loop regulates clinical outcome in bladder cancer Mónica Martínez‐Fernández, Marta Dueñas, Andrew Feber, Oncotarget Transcriptional RegulationUrologyMir-200 Family MembersBc ProgressionGenitourinary Cancer	2015	45
Blood mRNA expression of REV3L and TYMS as potential predictive biomarkers from platinum-based chemotherapy plus pemetrexed in non-small cell lung cancer patients M. Teresa Agulló-Ortuño, Inmaculada García‐Ruiz, C. Vanesa Díaz-García, Cancer Chemotherapy and Pharmacology Prognostic BiomarkersPotential Predictive BiomarkersMedicineImmunologyBlood Mrna Expression	2019	28
Evaluation of novel trans-sulfonamide platinum complexes against tumor cell lines Carlos Pérez‐Plasencia, C. Vanesa Díaz-García, Alba Agudo-López, European Journal of Medicinal Chemistry NanomedicineMedicinal ChemistryPolymer-drug ConjugateNatural SciencesCoordination Complex	2014	27
Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer M. Teresa Agulló-Ortuño, C. Vanesa Díaz-García, Alba Agudo-López, Journal of Cancer Research and Clinical Oncology Non-small-cell Lung CancerPrognostic FactorReceptor Gene ExpressionMedicinePathology	2014	19
Fecal microbiota transplantation alters the proteomic landscape of inflammation in HIV: identifying bacterial drivers C. Vanesa Díaz-García, Elena Moreno, Alba Talavera-Rodríguez, Microbiome	2024	17
Mechanistic added value of a trans-Sulfonamide-Platinum-Complex in human melanoma cell lines and synergism with cis-Platin Alba Agudo-López, Elena Prieto‐García, José Alemán, Molecular Cancer	2017	16
Tumor–Stromal Interactions in a Co-Culture Model of Human Pancreatic Adenocarcinoma Cells and Fibroblasts and Their Connection with Tumor Spread Elena Prieto‐García, C. Vanesa Díaz-García, Alba Agudo-López, Biomedicines	2021	15
Topical heparin as an effective and safe treatment for patients with capecitabine-induced hand-foot syndrome: results of a phase IIA trial supported by proteomic profiling of skin biopsies Analia Rodríguez Garzotto, Lara Iglesias-Docampo, C. Vanesa Díaz-García, Therapeutic Advances in Medical Oncology	2022	14

Page 1